1,25-Dihydroxyvitamin D3 (1,25(OH2D3) is considered to be the functional metabolite of vitamin D3 which stimulates the expression of hormone-specific genes via genomic action. Recently, this sterol has been identified in the regulation of such diverse biologic phenomena as protein synthesis and secretion, enzyme activity, and changes in cell morphology and differentiation. We propose to utilize several mammalian cultured cell lines in which appropriate bioresponses to vitamin D3 have been identified, including human intestine cells (407), human leukemic cells (HL-60), pig kidney cells (LLC-PK1), rat osteosarcoma cells (ROS 17/2.8), and mouse fibroblasts (3T6), to elucidate the mechanism(s) of the sterol's action. We will initially examine the characteristics of interaction between 1,25(OH)2D3 and the intact cell, its binding to specific cytoplasmic receptors, and its effects on transcriptional parameters. Regulation of biologic activity by 1,25(OH)2D3 will be examined at 4 levels: i) molecular (CaBP, collagen, and actin synthesis), ii) enzymatic (vitamin D3-24-OHase), iii) plasma membrane (Ca++ transport), and iv) cellular control (morphology and differentiation). We will investigate the effects of vitamin D3 metabolites on cultured cell responses, and attempt to correlate the extent of the response with both the administered vitamin D3 metabolite concentration, receptor presence, and the degree of receptor occupancy. Inhibitor studies (actinomycin D, butyrate, cycloheximide) will be utilized to further define the level at which the cultured cell responds to 1,25(OH)2D3. Finally, DNA binding site-specific antireceptor antibodies will be utilized in microinjection studies as selective blockers of the receptor-mediated nuclear action of the hormone, thus permitting evaluation of receptor requirements and identification of non-genomic ativities of 1,25(OH)2D3. This approach is expected to further define the relationship between vitamin D3 and newly identified cellular bioresponses, and in particular, the mechanism by which these activities are promoted. We feel that the proposed experiments may reveal important clues as to the regulation of processes involved in cell differentiation, a phenomenon crucially important to our understanding of human cancers.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK033351-03
Application #
3231770
Study Section
General Medicine B Study Section (GMB)
Project Start
1984-07-01
Project End
1987-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
Schools of Medicine
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85722
Sabir, Marya S; Haussler, Mark R; Mallick, Sanchita et al. (2018) Optimal vitamin D spurs serotonin: 1,25-dihydroxyvitamin D represses serotonin reuptake transport (SERT) and degradation (MAO-A) gene expression in cultured rat serotonergic neuronal cell lines. Genes Nutr 13:19
Karrys, Amitis; Rady, Islam; Chamcheu, Roxane-Cherille N et al. (2018) Bioactive Dietary VDR Ligands Regulate Genes Encoding Biomarkers of Skin Repair That Are Associated with Risk for Psoriasis. Nutrients 10:
Sabir, Marya S; Khan, Zainab; Hu, Chengcheng et al. (2017) SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D3 signaling via vitamin D receptor deacetylation. J Steroid Biochem Mol Biol 172:117-129
Haussler, Mark R; Whitfield, G Kerr; Haussler, Carol A et al. (2016) 1,25-Dihydroxyvitamin D and Klotho: A Tale of Two Renal Hormones Coming of Age. Vitam Horm 100:165-230
Dampf Stone, Angelika; Batie, Shane F; Sabir, Marya S et al. (2015) Resveratrol potentiates vitamin D and nuclear receptor signaling. J Cell Biochem 116:1130-43
Kaneko, Ichiro; Saini, Rimpi K; Griffin, Kristin P et al. (2015) FGF23 gene regulation by 1,25-dihydroxyvitamin D: opposing effects in adipocytes and osteocytes. J Endocrinol 226:155-66
Hsieh, Jui-Cheng; Estess, Rudolf C; Kaneko, Ichiro et al. (2014) Vitamin D receptor-mediated control of Soggy, Wise, and Hairless gene expression in keratinocytes. J Endocrinol 220:165-78
Austin, Heather R; Hoss, Elika; Batie, Shane F et al. (2014) Regulation of late cornified envelope genes relevant to psoriasis risk by plant-derived cyanidin. Biochem Biophys Res Commun 443:1275-9
Saini, Rimpi K; Kaneko, Ichiro; Jurutka, Peter W et al. (2013) 1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6. Calcif Tissue Int 92:339-53
Hoss, Elika; Austin, Heather R; Batie, Shane F et al. (2013) Control of late cornified envelope genes relevant to psoriasis risk: upregulation by 1,25-dihydroxyvitamin D3 and plant-derived delphinidin. Arch Dermatol Res 305:867-78

Showing the most recent 10 out of 60 publications